Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2,” by Kush M Parmar et al.
Research article
	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 116      Number 1      January 2006  49
Integration of flow-dependent endothelial 
phenotypes by Kruppel-like factor 2
Kush M. Parmar,1 H. Benjamin Larman,1 Guohao Dai,1 Yuzhi Zhang,1 Eric T. Wang,1  
Sripriya N. Moorthy,1 Johannes R. Kratz,1 Zhiyong Lin,2 Mukesh K. Jain,2  
Michael A. Gimbrone Jr.,1 and Guillermo García-Cardeña1
1Center for Excellence in Vascular Biology, Departments of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, 















































Endothelial KLF2 expression is selectively induced by a distinct type of flow 





























































Flow-dependent expression of KLF2 and its regulation by a MEK5/ERK5/MEF2 pathway. (A) Archetypal atheroprotective and atheroprone shear 
stress waveforms derived from a human carotid artery, as previously described (4). These 2 shear stress waveforms were recreated using a 
dynamic flow system and applied to cultured HUVECs. (B) HUVECs were cultured under static (no flow), atheroprone, or atheroprotective flow 
conditions for 24 hours, and KLF2 mRNA expression was measured by RT-PCR (n = 3; mean ± SEM). (C) Whole-mount in situ hybridization 
of WT or sih mutant embryos at 48 hours, probed for Flk or KLF2a. Inserts show close-ups of the trunk vasculature. Anal sphincter staining is 
indicated by arrowheads. (D) ChIP of MEF2A and MEF2C with the KLF2 promoter under static conditions and flow. (E) KLF2 mRNA in HUVECs 
infected with control (GFP) or dominant negative MEF2 (MEF2ASA) adenovirus 24 hours before exposure to the static (no flow) or atheropro-
tective waveform. (F) Western blot of total immunoprecipitated ERK5 and p-ERK5 from HUVECs under static or flow 24 hours after infection 
with control (GFP) or MEK5-DN adenovirus. (G) KLF2 mRNA levels from experimental samples represented in F. (H) Western blot of ERK5 
immunoprecipitates under conditions described in F from HUVECs infected with GFP or MEK5-CA adenovirus. (I) KLF2 mRNA from samples 
represented in H. *P < 0.05, **P < 0.01 vs. control; Student’s t test. ctrl, control.
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cal  for  the  MEF2-dependent  upregulation  of 
KLF2 under flow, HUVECs were infected with 
adenovirus expressing GFP or a dominant nega-
































Elucidation of KLF2-regulated global gene expression programs. (A) Visualization 
of whole-genome expression patterns controlled by KLF2 and/or IL-1b in HUVECs. 
HUVECs were infected with either Ad-GFP or Ad-KLF2 and incubated for 24 hours 
before RNA was isolated and analyzed using whole genome microarrays. Self-orga-
nizing map software was used to cluster similarly regulated genes and colorize them 
based on intensity of expression relative to GFP-expressing (control) cells. (B) Select-
ed KLF2-responsive genes grouped by clusters shown in A, with major associated 
biological functions listed. Dev, development.
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induction of tissue factor (TF) in cultured human endothelial 



















KLF2  but  are  not  modulated  by 
IL-1b  (e.g.,  angiopoietin-2  [Ang-2], 
endothelial lipase). Cluster II repre-
sents genes that are upregulated 
by  KLF2  and  not  regulated  by 
IL-1b (e.g., NFATc3, eNOS). Clus-


























analysis.  As  shown  in  Figure  3, 






















KLF2 regulates genetic programs controlling blood vessel development, vascular tone, and thrombo-
sis/hemostasis. (A) HUVECs under the same conditions as in Figure 2A were analyzed by quantitative 
TaqMan RT-PCR (n = 3) of the indicated genes; Ad-GFP was performed as the control. (B) Ang-2 
protein levels in supernatants were measured by ELISA under the same conditions (n = 3) as in A, 
but with an 8-hour incubation with IL-1b. Ang-2 levels shown are after subtraction of the amount in the 
media before conditioning. (C) Western blot of Tie2 and GAPDH (loading control) on whole-cell lysate 
of HUVECs infected with Ad-GFP or Ad-KLF2 for 24 hours. (D) Quantitative TaqMan RT-PCR was 
performed to assess the levels of expression of eNOS, ASS, CNP, and ET-1. (E) CNP protein levels in 
supernatant measured by ELISA. Supernatant was collected from HUVECs infected with the indicated 
adenoviruses for 24 hours with or without IL-1b. nd, not detectable. (F) Effect of KLF2 and/or IL-1b 
on the expression of major genes involved in thrombosis. Quantitative TaqMan RT-PCR of indicated 
genes was performed as described in A. EDG-1, endothelial differentiation gene 1; PAI-1, plasminogen 
activatory inhibitor 1. (G) FACS analysis of surface TM (TM/CD141) expression on HUVECs infected 
with Ad-GFP or Ad-KLF2 for 24 hours. (H) FACS analysis of cell-surface TF expression on HUVECs 
infected with the indicated virus followed by incubation with media or IL-1b (10 U/ml) for 6 hours. Bar 
graphs represent mean ± SEM (n = 3). *P < 0.05, **P < 0.01 vs. control; Student’s t test.
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We  next  evaluated  the  KLF2-mediated  regulation  of  genes 
involved in hemostasis, thrombosis, and inflammation. KLF2 




















mediated  increase  of  a  large  number  of  proinflam-
matory genes was muted by KLF2  (Figure 2B,  cluster 
III). Quantitative real-time PCR analysis of numerous 



























Effect of KLF2 and/or IL-1b on inflammatory gene expression by quantita-
tive TaqMan RT-PCR
Gene name Ad-GFP Ad-KLF2 Ad-GFP + IL-1b Ad-KLF2 + IL-1b
IL-6 1.0 –1.8 (0.3) 144.8 (63.5) 24.3 (7.4)A
IL-8 1.0 –4.1 (0.1) 206.4 (107.1) 31.5 (11.3)A
MCP-1 1.0 –2.6 (0.2) 140.9 (78.7) 19.9 (1.5)A
E-selectin 1.0 –3.47 (0.1) 122.3 (59.4) 25.7 (8.8)_
TNF 1.0 1.5 (0.9) 246.9 (75.8) 85.6 (65.1)_
CXCL10/IP-10 1.0 –1.4 (0.4) 674.7 (62.5) 62.8 (28.9)A
CXCL11/I-TAC 1.0 –1.8 (0.4) 22.4 (16.3) 1.9 (0.8)_
IFN-g 1.0 –2.6 (0.12) 143.9 (28.4) 23.9 (9.5)A
COX-2 1.0 –1.2 (0.2) 16.8 (5.2) 1.8 (1.4)A
CCL5 1.0 1.2 (0.2) 34.7 (6.5) 11.7 (2.9)A
IL-15 1.0 2.1 (0.7) 18.2 (1.4) 5.1 (0.9)A
IL-1a 1.0 5.7 (1.4) 55.2 (15.7) 15.5 (6.9)A
IL-1b 1.0 16.8 (11.1) 73.7 (8.9) 34.3 (16.3)A
Data are shown as mean relative to control (SD) for n = 3. AP < 0.05 vs.  
Ad-GFP + IL-1b.
Figure 4
KLF2 mediates a global antiinflammatory program in 
endothelial cells. (A) Protein levels of cytokines in superna-
tants of HUVECs infected with the indicated virus and then 
incubated with either normal media or IL-1b (10 U/ml) for 
24 hours. Samples were analyzed by multiplex ELISA or 
cytokine chip. IP-10, IFN-g–inducible protein 10. (B) Regu-
lation of PTGDS gene expression by KLF2 and/or IL-1b. 
(C) ELISA of 15d-PGJ2 after extraction from supernatants 
of cells infected with the indicated virus for 24 hours. (D) 
ELAFIN secretion measured by ELISA from supernatants 
under conditions described in A. All data are expressed 
as mean ± SEM (n = 3). *P < 0.05, **P < 0.01 vs. control; 
Student’s t test.
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id,  we  blocked  the  flow-induced 
upregulation of KLF2 using small 





under  static  control  conditions 


















gene  (NOV)  (Figure  5A).  The 
downregulation  of  IL-8,  Ang-2, 
and ET-1 by  flow was also abol-
ished at  the mRNA level  (Figure 





and  secreted  levels  of  15d-PGJ2 
were  also  abolished  by  blocking 
the flow-dependent upregulation 
of KLF2 (Figure 5, D–F).
To  obtain  an  unbiased  global 
picture of the role of KLF2 in the 



















Endothelial transcriptional programs evoked by atheroprotective flow require KLF2 expression. (A) 
Effects of suppressing flow-dependent KLF2 upregulation on gene expression. Cells were treated with 
either scrambled siRNA or siRNA targeting KLF2 for 24 hours and then placed under static or atheropro-
tective conditions for an additional 24 hours. Shown are RT-PCR data for the indicated genes. hPGT, 
human prostaglandin transporter; NOV, nephroblastoma overexpressed gene. (B) Monitoring of the 
interferon response in HUVECs treated with control or KLF2 siRNAs. Gene expression of 2′-5′-oligoad-
enylate synthetase (OAS2) or interferon-inducible transmembrane protein 1 (IFITM1) was assessed 
by TaqMan RT-PCR. As a positive control for the interferon response, HUVECs were incubated with 
long double-stranded RNA (dsRNA) poly I:C for 24 hours (n = 3). (C) Western blot for proteins in the 
same samples as represented in A. (D) Surface TM FACS on HUVECs under the indicated conditions. 
(E) ELISA of CNP from supernatants under the conditions described in A. (F) 15-d-PGJ2 levels in 
supernatants under the indicated conditions. (G) Histogram (blue bars) of genes binned according to 
fold regulation under flow. Overlaid on the histogram is a graph showing the percentage of genes within 
each bin that are KLF2 dependent (red diamonds and trend line). Gray shading indicates the portion 
of the histogram representing the 74 most highly regulated genes under flow (see text). All data are 
expressed as mean ± SEM (n = 3). *P < 0.05, **P < 0.01 vs. control; Student’s t test.
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static conditions and  is not  substantially altered upon  flow, 
indicating that this family appears to tonically bind to the KLF2 
Figure 6
KLF2 expression is essential for endothelial cellular pheno-
types conferred by flow. (A) HL-60 cell adhesion to HUVEC 
monolayers under the indicated conditions. After precondi-
tioning (static or atheroprotective flow), the cells were treat-
ed with 1 U/ml of IL-1b for 6 hours and then incubated with 
fluorescently labeled HL-60 cells. Shown are representative 
fields of HUVEC monolayers (blue) and attached monocytes 
(yellow). The bar graph on the right displays quantification 
of bound HL-60 cells. (B) Role of KLF2 in flow-mediated 
resistance to oxidant stress. Cells under static conditions 
(top row) were infected with either Ad-GFP or Ad-KLF2 for 
24 hours, and cells preconditioned with atheroprotective 
flow (bottom row) were treated with control or KLF2 siRNA. 
Cells were then incubated with or without 200 mM tert-butyl 
H2O2 for an additional 4 hours. (C) Total protein from GFP- or 
KLF2-expressing HUVECs blotted for catalase, manganese 
superoxide dismutase (MnSOD), or a-tubulin as a loading 
control. All data are expressed as mean ± SEM (n = 3). 
*P < 0.05 versus control; Student’s t test.
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